Key Findings:  Data suggests that cannabis using patients did not demonstrate more frequent active disease or IBD-associated complications. As such, the authors posit that other non-luminal (organ cavity) factors influenced their symptoms and/or decision to use cannabis.
Type of Study:  Meta-analysis
Study Sample Size:  383
Study Result:  Inconclusive
Research Location(s):  United States
Year of Pub:  2021
Cannabinoids Studied:  Cannabinoid (unspecified)
Phytocannabinoid Source:  Unspecified
Citation:  Coates MD, et al. Symptoms and Extraintestinal Manifestations in Active Cannabis Users with Inflammatory Bowel Disease. Cannabis Cannabinoid Res. 2022; 7:445-450. doi: 10.1089/can.2020.0155
Authors:  Coates MD, Dalessio S, Walter V, Stuart A, Bernasko N, Tinsley A, Razeghi S, Williams ED, Clarke K, Vrana K